FDA Drug Application (202150) for MOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE by HERITAGE PHARMS INC

Back to FDA Applications sponsored by HERITAGE PHARMS INC

Application Number202150
Product Number001
FormTABLET;ORAL
Dosage12.5MG;7.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameMOEXIPRIL HYDROCHLORIDE AND HYDROCHOLROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient MOEXIPRIL HYDROCHLORIDE5


Back to FDA Applications sponsored by HERITAGE PHARMS INC